Skip to content
Accessibility help

Search NICE…

Skip to content

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About

Search results

Skip to results

Area of interest

Area of interestAntimicrobial prescribing (43)COVID-19 (36)

Type

TypeGuidance (3883)Indicators (267)News (230)NICE advice (496)Quality standards (255)Research recommendations (1922)

Status

StatusAwaiting development (328)Discontinued (382)In consultation (6)In development (422)Published (2460)Topic selection (289)

Last updated

Last updatedLast 3 months (60)Last 6 months (142)Last year (584)Last 3 years (1774)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (25)Cancer service guidelines (10)Clinical guidelines (380)COVID-19 NHSE/I specialty guides (2)COVID-19 rapid guidelines (27)Diagnostics guidance (93)Health technology evaluations (38)Highly specialised technologies guidance (47)Interventional procedures guidance (950)Medical technologies guidance (154)Medicines practice guidelines (5)NICE guidelines (562)Public health guidelines (88)Safe staffing guidelines (7)Social care guidelines (47)Technology appraisal guidance (2035)

Advice programme

Advice programmeCOVID-19 rapid summaries (8)Evidence summaries (172)Medtech innovation briefings (324)

Showing 6796 to 6810 of 7681 results

Sort by

Enasidenib for treating IDH2-positive acute myeloid leukaemia after 2 or more therapies [ID1455]
Discontinued [GID-TA10356]
Result type
Technology appraisal guidance
Status
Discontinued
Durvalumab with tremelimumab for treating squamous cell head and neck cancer after platinum-based chemotherapy [ID1144]
Discontinued [GID-TA10474]
Result type
Technology appraisal guidance
Status
Discontinued
Ofatumumab (Arzerra) in combination with chemotherapy for follicular lymphoma; second line - refractory to rituximab [ID1487]
Discontinued [GID-TA10437]
Result type
Technology appraisal guidance
Status
Discontinued
Abemaciclib for treating KRAS mutation-positive non-small-cell lung cancer after platinum-based chemotherapy [ID1147]
Discontinued [GID-TA10343]
Result type
Technology appraisal guidance
Status
Discontinued
Durvalumab for treating recurrent or metastatic squamous cell head and neck cancer after platinum-based chemotherapy [ID1231]
Discontinued [GID-TA10473]
Result type
Technology appraisal guidance
Status
Discontinued
Listeria monocytogenes vaccine for previously treated malignant pleural mesothelioma ID1353
Discontinued [GID-TA10320]
Result type
Technology appraisal guidance
Status
Discontinued
Carotuximab with pazopanib for treating advanced angiosarcoma [ID1503]
Discontinued [GID-TA10401]
Result type
Technology appraisal guidance
Status
Discontinued
Masitinib for treating malignant melanoma that has a c-Kit juxtamembrane mutation [ID1082]
Discontinued [GID-TA10627]
Result type
Technology appraisal guidance
Status
Discontinued
Masitinib for treating relapsed or refractory peripheral T-cell non-Hodgkin lymphoma [ID1125]
Discontinued [GID-TA11173]
Result type
Technology appraisal guidance
Status
Discontinued
Atezolizumab with cobimetinib for untreated BRAF wild-type metastatic melanoma [ID1470]
Discontinued [GID-TA10354]
Result type
Technology appraisal guidance
Status
Discontinued
Lenalidomide with R-CHOP for untreated activated diffuse large B-cell lymphoma [ID1611]
Discontinued [GID-TA10480]
Result type
Technology appraisal guidance
Status
Discontinued
Eltrombopag for untreated severe aplastic anaemia [ID1198]
Discontinued [GID-TA10284]
Result type
Technology appraisal guidance
Status
Discontinued
Renal cell carcinoma - sunitinib [ID1076]
Discontinued [GID-TA10166]
Result type
Technology appraisal guidance
Status
Discontinued
Nivolumab with ipilimumab for previously treated extensive stage small-cell lung cancer [ID1228]
Discontinued [GID-TA10203]
Result type
Technology appraisal guidance
Status
Discontinued
NGR-TNF for previously treated advanced malignant pleural mesothelioma [ID655]
Discontinued [GID-TA10183]
Result type
Technology appraisal guidance
Status
Discontinued

Previous page
1
…
452
453
Current page 454
455
456
…
513
Page 454 of 513
Next page

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Knowledge resources

About NICE
Into practice
Get involved with NICE
Jobs
News
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2024. All rights reserved. Subject to Notice of rights.